Shin Sik Choi
Wednesday 3rd July 2024, 09:00-10:00
Human biological system mimic nano-complexation for pharmaceuticals/cosmetics/functional foods
Dr. Choi, Shin Sik received his PhD from Seoul National University, Korea and performed postdoctoral research in University of California Santa Barbara, USA. He has been working in Myongji University, Korea as a professor for 15 years and recently founded “elegslab”, with two business models: nano-CDMO and C. elegans-CRO. The nano-CDMO covers nano-formulation or nano-complexation of clients’ drug (chemicals, genes, proteins etc)/functional food/cosmetic ingredients using elegslab’s cutting-edge nanotechnology. The C. elegans-CRO helps clients discover novel drug candidates from 1,000-100,000 libraries through elegslab’s in vivo screening system and conduct toxicity/efficacy non-clinical test using a fantastic animal testing alternative model organism, C. elegans.
Visit us on Social Media
#ECB2024
Please note: All information requested on the website and registration process is strictly for the use of the Congress in compliance with international privacy legislation. By completing this registration form you will agree that the Congress will use this data to keep you fully informed of the Congress in 2024. The data will then be retained by the Congress secretariat for the purposes of informing you about activities and future meetings. On the registration form, You will also have the opportunity to agree separately to allow key data (Name, Company, Email Address) to be shared with sponsors and exhibitors who are participating in the Congress in 2024. We will not pass any details to any companies not participating in the Congress in 2024.